March 25, 2009. Our groups representing patient, consumer, science and public health interests submit the following comments regarding the draft approach prepared by CPSC staff for determining which products constitute a children’s toy or child care article and are subject to section 108 of the CPSIA.
Read More »On Health Policy
Letter to U.S. Rep. Henry Waxman (Chairmen of the Energy and Commerce Committee) Supporting the “Ban Poisonous Additives Act of 2009″
March 18, 2009. The Centers for Disease Control and Prevention (CDC) found BPA in more than 90 percent of Americans tested for the chemical, and BPA is linked to numerous adverse health effects.
Read More »Letter to U.S. Senator Feinstein (CA) Strongly Supporting the “Ban Poisonous Additives Act of 2009”
March 18, 2009. The above members of the Patient and Consumer Coalition strongly support S. 593, the “Ban Poisonous Additives Act of 2009,” which will remove Bisphenol A (BPA) from food and beverage containers.
Read More »Letter to U.S. Rep. Frank Pallone (Chairman of the Energy and Commerce Subcommittee on Health) Supporting the Medical Device Safety Act of 2009
March 2, 2009. Last year, the U.S. Supreme Court ruled in Riegel v. Medtronic, Inc. that medical devices makers are shielded from personal injury lawsuits, if their defective or unsafe product was approved by the Food and Drug Administration’s (FDA) pre-market approval (PMA) process.
Read More »NCHR Testimony at FDA Science Board Meeting on the Use of Bisphenol A in Food Containers
February 24, 2009. NCHR was very pleased with the Science Board’s criticisms of the FDA Draft report on BPA and were disappointed that the FDA has not acknowledged the bottom line criticism: that the FDA drew conclusions about the safety of BPA that were not based on sound science, and that no conclusions can be made about safety until the FDA pays attention to the best studies conducted by federally funded scientists and designs appropriate follow-up research.
Read More »